Role of the Kynurenine System in Neurological Disorders

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".

Deadline for manuscript submissions: closed (31 March 2026) | Viewed by 2472

Special Issue Editors


E-Mail Website
Guest Editor
Department of Theoretical Health Sciences and Health Management, Faculty of Health Sciences and Social Studies, University of Szeged, H-6726 Szeged, Hungary
Interests: kynurenine pathway; endocannabinoid system; migraine

E-Mail Website
Guest Editor
Department of Theoretical Health Sciences and Health Management, Faculty of Health Sciences and Social Studies, University of Szeged, H-6726 Szeged, Hungary
Interests: kynurenine pathway; migraine

Special Issue Information

Dear Colleagues,

The kynurenine system is a metabolic pathway that breaks down the amino acid tryptophan into several bioactive compounds, including kynurenine and its metabolites. This pathway plays a critical role in regulating immune responses, neuroinflammation, and neurotransmitter balance in the brain. Recent research has highlighted the significance of the kynurenine system in neurological disorders, particularly due to the production of neurotoxic and neuroprotective metabolites. Key metabolites such as quinolinic acid (QUIN) and kynurenic acid (KYNA) are of particular interest. QUIN is excitotoxic, meaning that it overstimulates neurons and can lead to neuronal damage and death, which is implicated in disorders like Alzheimer's disease, Parkinson's disease, and multiple sclerosis. KYNA, on the other hand, acts as a neuroprotectant by blocking excitatory neurotransmitters like glutamate, potentially offering a protective role against neurodegeneration. In neuroinflammatory diseases, an imbalance between these metabolites contributes to disease progression. Chronic activation of the immune system, as seen in neurodegenerative disorders, increases the production of QUIN, leading to further neuronal damage. This shift towards neurotoxic metabolite production has been implicated in conditions such as depression, schizophrenia, and Huntington’s disease. Understanding the regulation of the kynurenine pathway and its role in the central nervous system provides a promising avenue for developing novel therapeutic strategies targeting neuroinflammation and neurodegeneration. Modulating this pathway may help restore balance and prevent further neurological damage.

Dr. Gábor Nagy-Grócz
Dr. Tamás Körtési
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • kynurenine pathway
  • neurological disorders
  • kynurenic acid
  • quinolinic acid

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

42 pages, 1761 KB  
Review
Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration
by Julia K. Banaszkiewicz, Anna Kukiełka, Elżbieta Kudyk, Łucja J. Walczak, Katarzyna Wicha-Komsta, Mariola Herbet, Iwona Piątkowska-Chmiel, Grzegorz Nowicki, Carmen E. Mielnik and Tomasz Kocki
Life 2026, 16(2), 266; https://doi.org/10.3390/life16020266 - 3 Feb 2026
Viewed by 1825
Abstract
Neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, are becoming an increasingly serious challenge for modern medicine because of the significant increase in incidence and the narrow range of effective therapeutic strategies. In recent years, the kynurenine pathway, which is one of the main [...] Read more.
Neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, are becoming an increasingly serious challenge for modern medicine because of the significant increase in incidence and the narrow range of effective therapeutic strategies. In recent years, the kynurenine pathway, which is one of the main pathways of tryptophan metabolism, responsible for the synthesis of products that act oppositely in the CNS including neurotoxic (quinolinic acid) and neuroprotective products, has gained increasing recognition as a potential therapeutic target. Abnormalities in the production of these metabolites, causing a disruption of homeostasis in the CNS, often lead to the development of inflammation, which can cause oxidative stress or neuronal death. This paper aims to discuss strategies useful in modulation of the kynurenine pathway, based on increasing the production of neuroprotective metabolites and reducing the synthesis of neurotoxic compounds, as well as to outline the progress in preclinical and clinical studies and the challenges encountered in these studies, among others, in the search for new KP inhibitors. The pharmacological (IDO and KMO inhibitors) and non-pharmacological (physical activity, diet) strategies are discussed, as well as new approaches from combination and targeted therapies. Together with the results of preclinical studies, they demonstrate the high utility of this target in the treatment of neurodegeneration. Despite its promising activity, further key studies are needed to fully understand the mechanisms involved in metabolism, which may translate into increased efficacy of developed therapies in the future. Full article
(This article belongs to the Special Issue Role of the Kynurenine System in Neurological Disorders)
Show Figures

Figure 1

Back to TopTop